AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine - Related Studies

AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine

This study is currently recruiting participants.

Study NCT00326872. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Neurofibromatosis Type 1 (nf1)
		Precancerous/Nonmalignant Condition

2	Additional conditions recognized in this trial
		Neurofibroma
		Neurofibroma, Plexiform
		Neurofibromatoses
		Neurofibromatosis 1
		Precancerous Conditions

3	More general conditions related to this trial
		Genetic Diseases, Inborn
		Heredodegenerative Disorders, Nervous System
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Nerve Tissue
		Neoplastic Syndromes, Hereditary
		Nerve Sheath Neoplasms
		Nervous System Diseases
		Nervous System Neoplasms
		Neurocutaneous Syndromes
		Neurodegenerative Diseases
		Neuromuscular Diseases
		Peripheral Nervous System Diseases
		Peripheral Nervous System Neoplasms

4	Interventions listed in this trial
		cediranib

5	Sponsors listed in this trial
		Mayo Clinic
		National Cancer Institute (NCI)